Pneumococcal vaccine schedules - results from a cluster-randomised trial in The Gambia
This webinar will present initial findings from a large-scale cluster-randomised trial conducted in The Gambia to compare the effects of reduced pneumococcal vaccine doses.
The pneumococcal schedules study (PVS) is a large cluster-randomised trial in rural Gambia comparing an alternative reduced dose, 2-dose schedule, to the standard 3-dose schedule. Over four years 33,001 infants in the study area were enrolled across 68 regional groups.
The presentation will discuss the design of the trial and its initial results. The finding from PVS has informed new WHO recommendations for reduced dose schedules of PCV.
Speaker
Dr Grant Mackenzie is a Professor of Global Child Health at °®ÍþÄÌapp of Hygiene & Tropical Medicine. He is an epidemiologist and paediatrician. He trained at the University of Melbourne, the Royal Children’s Hospital in Melbourne and in Darwin in the tropical north of Australia. He has been a Clinical Epidemiologist with the MRC Unit The Gambia at LSHTM since 2008. Professor Mackenzie is currently conducting a large cluster-randomised trial of different pneumococcal vaccine schedules. His research interests include acute respiratory infections, sepsis, and meningitis with a focus on vulnerable and malnourished children and a motivation to reduce child mortality through vaccination.
Event notices
- Please note this event is virtual only.
- Please note that the recording link will be listed on this page when available.
Admission
Contact
